Two Sigma Investments
VERV

Two Sigma Investments’s Verve Therapeutics VERV Stock Holding History

Two Sigma Investments’s Portfolio VERV Stock Details VERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-812,360
Closed -$9.12M – 3944
2025
Q2 		$9.12M Buy
812,360
+432,779
+114% +$2.47M 0.02% 870
2025
Q1 		$1.73M Sell
379,581
-190,723
-33% -$1.28M ﹤0.01% 1832
2024
Q4 		$3.22M Buy
570,304
+140,030
+33% +$790K 0.01% 1399
2024
Q3 		$2.08M Sell
430,274
-177,199
-29% -$1.03M ﹤0.01% 1659
2024
Q2 		$2.96M Buy
607,473
+361,891
+147% +$2.27M 0.01% 1292
2024
Q1 		$3.26M Buy
245,582
+169,069
+221% +$2.24M 0.01% 1192
2023
Q4 		$1.07M Buy
+76,513
New +$948K ﹤0.01% 2036
2023
Q2 		– Sell
-141,756
Closed -$2.04M – 3275
2023
Q1 		$2.04M Buy
+141,756
New +$2.78M 0.01% 1365
2022
Q3 		– Sell
-56,781
Closed -$868K – 2842
2022
Q2 		$868K Buy
56,781
+29,187
+106% +$452K ﹤0.01% 1605
2022
Q1 		$630K Buy
+27,594
New +$789K ﹤0.01% 1909

Other funds holding VERV

GCM
Greenland Capital Management New York $787M AUM 40.68% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
BIG
Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Two Sigma Investments's VERV Position: Q3 2025 in Review

Two Sigma Investments sold out of Verve Therapeutics (VERV) in Q3 2025, closing a stake of 812,360 shares — an estimated $9.12M sold.

Two Sigma Investments first reported a position in VERV in Q1 2022 and held it in 10 quarters. The position peaked at $9.12M in Q2 2025. 6 funds tracked by Wall St. Rank hold VERV as of Q3 2025.

  • Two Sigma Investments reported no remaining Verve Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Two Sigma Investments sold 812,360 Verve Therapeutics shares in Q3 2025, an estimated $9.12M.
  • Two Sigma Investments first reported a position in Verve Therapeutics in Q1 2022 and held it in 10 quarters.
  • Two Sigma Investments's Verve Therapeutics position peaked at $9.12M in Q2 2025.
  • 6 funds tracked by Wall St. Rank held Verve Therapeutics as of Q3 2025.

Based on Two Sigma Investments's 13F filing for Q3 2025, filed 14 Nov 2025.